According to FutureWise analysis the market for pulmonary surfactant in 2023 is US$ 0.6 billion, and is expected to reach US$ 0.86 billion by 2031 at a CAGR of 4.7%.
A lung disorder called surfactant dysfunction causes breathing problems. A disorder caused by abnormalities in surfactant, a mixture of certain fats (called phospholipids), and proteins inside the lungs that make breathing easy, is called emphysema. In the absence of normal surfactant, the tissue surrounding the air sacs in the lungs (alveoli) sticks together (due to surface tension), causing them to collapse upon exhalation. In turn, breath-by-breath filling of the lungs with air becomes difficult, which in turn leads to reduced oxygen delivery. It can be difficult to determine the severity of signs and symptoms associated with surfactant dysfunction. Newborns suffering from respiratory distress syndrome suffer from the most severe form of this condition. It is extremely difficult for babies with this disease to breathe and they do not get enough oxygen as a result. It is possible to damage the baby's brain and other organs if the baby does not receive enough oxygen. Babies with this form of the condition often die within a few months of being born due to respiratory failure. It is possible for children or adults to develop breathing problems gradually as a result of mild forms of surfactant dysfunction. There are milder forms of this condition, such as tachypnea, hypoxemia, and failure to thrive. The signs and symptoms are rapid breathing (tachypnea), low blood oxygen concentrations (hypoxemia), and a failure to gain weight. Genetic causes of surfactant dysfunction can be used to identify various types of the condition. Infants suffering from respiratory distress syndrome are caused by a type of condition called SP-B deficiency. The third type of dysfunction, called SP-C dysfunction and ABCA3 deficiency, is characterized by mild to severe signs and symptoms.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Pulmonary Surfactant Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Pulmonary Surfactant Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.